ernstlaboratory.bsky.social
ernstlaboratory.bsky.social
ernstlaboratory.bsky.social
@ernstlaboratory.bsky.social
Research is our game: scientists aiming to understand stem cells and leukemia to benefit health
@paralkarlab.bsky.social
Hello, since you are a hematology/oncology influencer, could you re-post my thing about the Myeloid Workshop being on despite ASH not getting it up on the website? Thank you!
November 4, 2025 at 11:43 PM
Important PSA! ASH Scientific Workshop website is experiencing a technical problem; YES, the Myeloid Workshop should be on the website and has an excellent speaker lineup already, stay tuned! @steidluli.bsky.social
November 2, 2025 at 6:10 PM
I hate to make this even more popular than it already is, but...had a really great experience. Cells on Thursday, results on Sunday..nice platform for data analysis too
November 2, 2025 at 5:44 PM
Reposted by ernstlaboratory.bsky.social
In a Flint Animal Cancer Center canine clinical trial, they are testing a novel combination of orally delivered drugs targeting metastasis-promoting white blood cells (WBC), in combination with reprogramming the patient’s cancer fighting WBC to seek out and destroy osteosarcoma.
September 30, 2025 at 4:47 PM
So jealous. ANA is the best too.
Excited to be heading out to #ISEH2025 in Kumamoto @isehsociety.bsky.social
September 23, 2025 at 1:13 PM
Reposted by ernstlaboratory.bsky.social
@eirinipapapetrou.bsky.social from the Icahn School of Medicine at Mount Sinai is excited for the rooftop party after the iPSC symposium the day before #ISEH2025 🏯 begins 🌃 Learn more about this event and register! sites.google.com/view/2025ips...
September 9, 2025 at 4:44 PM
Reposted by ernstlaboratory.bsky.social
Take advantage of the chance to see your international friends like Hitoshi Takizawa, PhD from Kumamoto University will be doing at #ISEH2025 🏯. Register for the meeting here: www.iseh.org/2025Registration
September 13, 2025 at 3:45 PM
Lucky you!
Super excited to attend the 54th @isehsociety.bsky.social
conference in Japan next week! First time in Japan. First time at a hematology conference. Great chance to network with the world's best and share our CH work in Down Syndrome.
@crnicinstitute.bsky.social @cuanschutz.bsky.social
September 22, 2025 at 11:26 PM
This is really cool. I have had a fantasy of knocking out pol II since the 90s, so it is really nice to see it finally done and thoroughly analyzed.
September 19, 2025 at 2:10 PM
Thank you so much!
Hill Day ready! 💪👏 ASH Advocacy Leadership Institute participants prepped to advocate for the Sickle Cell Disease Care Act & NIH funding to support lifesaving blood disorder research. Tomorrow, they take their message to Capitol Hill.

Join the fight: https://bit.ly/3YeapvY

#Fight4Hematology
September 9, 2025 at 12:19 AM
and MCO members...@cucancercenter.bsky.social
Yeah Varuna's thesis work is out!!!!! congratulations Varuna and Sabrina et al
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
September 8, 2025 at 4:34 PM
Yeah Varuna's thesis work is out!!!!! congratulations Varuna and Sabrina et al
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells
Cyclin D1 accumulation enables a switch in melanoma cells from drug-induced quiescence to proliferation.
scim.ag
September 5, 2025 at 8:12 PM
Reposted by ernstlaboratory.bsky.social
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells
Cyclin D1 accumulation enables a switch in melanoma cells from drug-induced quiescence to proliferation.
scim.ag
September 5, 2025 at 3:00 PM
Reposted by ernstlaboratory.bsky.social
We have new members! Welcome to the CU Cancer Center! 👏
August 17, 2025 at 12:58 AM
Congratulations @mary-flores.bsky.social‬! what an honor for the lab too ‪@chrmosimann.bsky.social‬
I’m honored to be selected as a Pew Latin American Fellow 2025! 🐟🧬🔬
With this opportunity, I will continue my postdoctoral training in the @chrmosimann.bsky.social lab at @cupediatrics.bsky.social/ @cudevbio.bsky.social , and it opens the door for me to return and established a lab in LATAM. 🇲🇽😍
August 13, 2025 at 12:33 PM
July 27, 2025 at 2:47 PM
www.biorxiv.org
July 27, 2025 at 2:44 PM
The Myeloid Workshop is back in ASH! Please contact the organizers if you have an exciting story that will not be out by December they are: Zuzana Tothova ,
@ernstlaboratory.bsky.social
@steidluli.bsky.social
@ericpietras.bsky.social
@kathrinbernt.bsky.social
@gritsmanlab.bsky.social
July 21, 2025 at 7:27 PM
Thank you!
ASH members are at Capitol Hill to stand up for hematology and advocate for policies that protect access to care for individuals with blood disorders.

#Fight4Hematology #HemeSky
April 29, 2025 at 4:27 PM
Reposted by ernstlaboratory.bsky.social
Everyone please read and act! 👇
ACTION ITEM-----ACTION ITEM

Implementation of Schedule F

This is what a lot of us have been worried about.

This allows for many civil service positions to replaced with political appointees. This could include NIH institute directors and even POs.

BUT THERE IS A COMMENT PERIOD...

1/n
the word alert is in a purple circle
ALT: the word alert is in a purple circle
media.tenor.com
April 23, 2025 at 9:00 PM